2.要約四半期連結財務諸表及び主な注記

(1)要約四半期連結財政状態計算書

 

 

 

(単位:千円)

 

前連結会計年度

(2023年12月31日)

 

当第3四半期連結会計期間

(2024年9月30日)

資産

 

 

 

非流動資産

 

 

 

有形固定資産

5,238,673

 

5,480,365

使用権資産

814,513

 

1,047,618

のれん

17,261,275

 

17,526,722

無形資産

3,690,331

 

4,636,676

持分法で会計処理されている投資

360,821

 

390,592

繰延税金資産

304,436

 

268,119

その他の金融資産

3,793,224

 

6,135,227

その他の非流動資産

23,811

 

非流動資産合計

31,487,087

 

35,485,323

 

 

 

 

流動資産

 

 

 

棚卸資産

2,330,622

 

2,602,812

営業債権及びその他の債権

3,973,476

 

4,754,445

その他の金融資産

1,577,274

 

4,601,997

その他の流動資産

1,392,881

 

1,254,817

現金及び現金同等物

21,633,028

 

14,049,285

流動資産合計

30,907,282

 

27,263,358

資産合計

62,394,370

 

62,748,681

 

 

 

 

負債及び資本

 

 

 

非流動負債

 

 

 

借入金

1,600,000

 

1,300,000

リース負債

150,276

 

292,393

繰延税金負債

1,173,159

 

1,283,900

その他の金融負債

15,139,232

 

13,613,691

その他の非流動負債

85,146

 

75,755

非流動負債合計

18,147,815

 

16,565,740

 

 

 

 

流動負債

 

 

 

営業債務及びその他の債務

2,064,776

 

1,543,547

借入金

1,300,000

 

4,600,000

1年内返済予定の長期借入金

400,000

 

400,000

リース負債

249,158

 

293,961

未払法人所得税

2,187,700

 

1,222,084

その他の金融負債

49,010

 

461,690

その他の流動負債

1,943,131

 

1,683,938

流動負債合計

8,193,776

 

10,205,221

負債合計

26,341,592

 

26,770,962

 

 

 

 

資本

 

 

 

資本金

13,052,056

 

13,223,623

資本剰余金

7,397,974

 

6,529,063

自己株式

15,302

 

15,302

利益剰余金

8,790,563

 

10,095,642

その他の資本の構成要素

4,569,122

 

3,261,272

親会社の所有者に帰属する持分合計

33,794,414

 

33,094,300

非支配持分

2,258,363

 

2,883,419

資本合計

36,052,778

 

35,977,719

資本及び負債の合計

62,394,370

 

62,748,681

 

E0571221600株式会社ジーエヌアイグループGNI Group Ltd.四半期第3号参考様式 [IFRS](連結)IFRStrueCTE2024-01-012024-09-30Q32024-12-312023-01-012023-09-302023-12-311falsefalsefalse216002023-01-012023-09-30216002023-09-30216002024-01-012024-09-30216002024-09-30216002024-11-14216002022-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002022-12-31jpigp_cor:ShareCapitalIFRSMember216002022-12-31jpigp_cor:CapitalSurplusIFRSMember216002022-12-31jpigp_cor:TreasurySharesIFRSMember216002022-12-31jpigp_cor:RetainedEarningsIFRSMember216002022-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002022-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002022-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002022-12-31jpigp_cor:NonControllingInterestsIFRSMember216002023-12-31jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-12-31jpigp_cor:ShareCapitalIFRSMember216002023-12-31jpigp_cor:CapitalSurplusIFRSMember216002023-12-31jpigp_cor:TreasurySharesIFRSMember216002023-12-31jpigp_cor:RetainedEarningsIFRSMember216002023-12-31jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-12-31jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-12-31jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-12-31jpigp_cor:NonControllingInterestsIFRSMember216002023-01-012023-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-01-012023-09-30jpigp_cor:ShareCapitalIFRSMember216002023-01-012023-09-30jpigp_cor:CapitalSurplusIFRSMember216002023-01-012023-09-30jpigp_cor:TreasurySharesIFRSMember216002023-01-012023-09-30jpigp_cor:RetainedEarningsIFRSMember216002023-01-012023-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002023-01-012023-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-01-012023-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-01-012023-09-30jpigp_cor:NonControllingInterestsIFRSMember216002023-12-31216002023-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002023-09-30jpigp_cor:ShareCapitalIFRSMember216002023-09-30jpigp_cor:CapitalSurplusIFRSMember216002023-09-30jpigp_cor:TreasurySharesIFRSMember216002023-09-30jpigp_cor:RetainedEarningsIFRSMember216002022-12-31216002023-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002023-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002023-09-30jpigp_cor:NonControllingInterestsIFRSMember216002024-01-012024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-01-012024-09-30jpigp_cor:ShareCapitalIFRSMember216002024-01-012024-09-30jpigp_cor:CapitalSurplusIFRSMember216002024-01-012024-09-30jpigp_cor:TreasurySharesIFRSMember216002024-01-012024-09-30jpigp_cor:RetainedEarningsIFRSMember216002024-01-012024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-01-012024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-01-012024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-01-012024-09-30jpigp_cor:NonControllingInterestsIFRSMember216002024-09-30jpigp_cor:EquityAttributableToOwnersOfParentIFRSMember216002024-09-30jpigp_cor:ShareCapitalIFRSMember216002024-09-30jpigp_cor:CapitalSurplusIFRSMember216002024-09-30jpigp_cor:TreasurySharesIFRSMember216002024-09-30jpigp_cor:RetainedEarningsIFRSMember216002024-09-30jpigp_cor:OtherComponentsOfEquityIFRSMember216002024-09-30jpigp_cor:ShareAcquisitionRightsIFRSMember216002024-09-30jpigp_cor:ExchangeDifferencesOnTranslationOfForeignOperationsIFRSMember216002024-09-30jpigp_cor:NonControllingInterestsIFRSMember216002023-01-012023-09-30jpcrp_cor:ReportableSegmentsMember216002023-01-012023-09-30tse-qcediffr-21600:PharmaceuticalReportableSegmentMember216002023-01-012023-09-30tse-qcediffr-21600:MedicalDeviceReportableSegmentMember216002023-01-012023-09-30jpcrp_cor:ReconcilingItemsMember216002024-01-012024-09-30jpcrp_cor:ReportableSegmentsMember216002024-01-012024-09-30tse-qcediffr-21600:PharmaceuticalReportableSegmentMember216002024-01-012024-09-30tse-qcediffr-21600:MedicalDeviceReportableSegmentMember216002024-01-012024-09-30jpcrp_cor:ReconcilingItemsMember216002023-09-30jpigp_cor:OtherComponentsOfEquityIFRSMemberiso4217:JPYxbrli:sharesiso4217:JPYxbrli:pure